Neuroendocrine Tumors

A Phase II Trial of Gefitinib (Iressa) in Patients With Chemosensitive and Chemorefractory Relapsed Neuroendocrine Cancers

Status
Cancer Types
Neuroendocrine Tumors
Locations

BTCRC-GI19-400

Prospective assessment of patients with neuroendocrine tumors and current or prior history of carcinoid syndrome or diarrhea undergoing peptide receptor radionuclide therapy with or without telotristat ethyl (NET-PACS Trial) Big Ten Cancer Research Consortium BTCRC-GI19-400
Status
Closed
Cancer Types
Neuroendocrine Tumors
Locations